Corpus Intelligence IC Memo — UNION HOSPITAL CLINTON 2026-04-27 00:04 UTC
IC Memo — UNION HOSPITAL CLINTON
Investment Committee Memorandum | IN | 25 beds | Grade C | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 151326

UNION HOSPITAL CLINTON

LOCATIONVERMILLION, IN·BEDS25·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

UNION HOSPITAL CLINTON is a 25-bed rural/critical access in VERMILLION, IN with $30.1M in net patient revenue and a 17.7% operating margin. The hospital serves a payer mix of 49.9% Medicare, 0.7% Medicaid, and 49.4% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.7% to 25.1% (+736bps).

Net Revenue HCRIS$30.1M
Current EBITDA COMPUTED$5.3M
Operating Margin COMPUTED17.7%
Occupancy HCRIS21.4%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS31.2%
Distress Probability ML54.7%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
86
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 17.7% places it above the state median. Among 86 size-comparable peers (12-50 beds), the median margin is -5.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UNION HOSPITAL CLINTON (Target)IN25$30.1M17.7%
INDIANA ORTHOPAEDIC HOSPITAL LIN38$196.8M31.2%
ORTHOPAEDIC HOSPT.AT PARKVIEWIN37$175.7M36.8%
LUTHERAN MUSCULOSKELETAL CENTEIN39$168.9M25.0%
WITHAM MEMORIAL HOSPITALIN50$158.5M-11.6%
MAJOR HOSPITALIN46$156.9M-9.2%
HENRY COUNTY MEMORIAL HOSPITALIN48$137.8M-1.7%
MARGARET MARY COMMUNITY HOSPITIN25$124.5M-3.6%
KINGS DAUGHTERS HOSPITALIN43$123.4M-13.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$633K+210bp18mo
Cost to Collect4.5%2.5%$602K+200bp12mo
Denial Rate Reduction12.0%6.5%$596K+198bp12mo
A/R Days Reduction5200.0%3800.0%$367K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$633K
Cost to Collect
$602K
Denial Rate Reduction
$596K
A/R Days Reduction
$367K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$5.3M
+ RCM Uplift+$2.2M
Pro Forma EBITDA$7.5M
Current Margin17.7%
Pro Forma Margin25.1%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.2M$57.3M6.99x47.5%
Base (11x exit)10.0x11.0x$8.2M$65.7M8.01x51.6%
Bull Case9.0x11.0x$7.4M$75.7M10.26x59.3%
Bull (12x exit)9.0x12.0x$7.4M$84.8M11.49x62.9%
Bear Case11.0x10.0x$9.0M$43.6M4.83x37.0%
Bear (11x exit)11.0x11.0x$9.0M$50.9M5.64x41.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 21.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 12-50 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-15.0% / P50=-5.6% / P75=6.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.